VIRAMABS

We are a company dedicated to developing neutralizing antibodies that can be used as a treatment for novel viruses. Our team is working on improving methods for rapid screening and cloning of cells that produce high-affinity antibodies for use in clinic. While developing virus-specific drugs can take long time, neutralizing antibodies can be produced relatively quickly making them an excellent first choice of treatment until the vaccine or antivirals are available.

Also known as: Viramabs, Inc.